Interleukin-1 (IL-1) Pathway

Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis

Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications - ScienceDirect

The Structural Pathway of Interleukin 1 (IL-1) Initiated Signaling Reveals Mechanisms of Oncogenic Mutations and SNPs in Inflammation and Cancer

Frontiers Interleukin-1 as Innate Mediator of T Cell Immunity

IL-1 pathways in inflammation and human diseases

The Role of Interleukin-1 in Disease

Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis

Frontiers Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease

Progress of research into the interleukin-1 family in CVD